Peserico A - Search Results

1

Erythroderma in the era of biological therapies.

Zattra E, Belloni Fortina A, Peserico A, Alaibac M. Zattra E, et al. Among authors: peserico a. Eur J Dermatol. 2012 Mar-Apr;22(2):167-71. doi: 10.1684/ejd.2011.1569. Eur J Dermatol. 2012. PMID: 22321651 Review.

2

Contact sensitization to Compositae mix in children.

Belloni Fortina A, Romano I, Peserico A. Belloni Fortina A, et al. Among authors: peserico a. J Am Acad Dermatol. 2005 Nov;53(5):877-80. doi: 10.1016/j.jaad.2005.07.015. J Am Acad Dermatol. 2005. PMID: 16243147

3

Contact sensitization in very young children.

Belloni Fortina A, Romano I, Peserico A, Eichenfield LF. Belloni Fortina A, et al. Among authors: peserico a. J Am Acad Dermatol. 2011 Oct;65(4):772-779. doi: 10.1016/j.jaad.2010.07.030. Epub 2011 May 25. J Am Acad Dermatol. 2011. PMID: 21616561

4

TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?

Zattra E, Stan R, Russo I, Lo Nigro A, Peserico A, Alaibac M. Zattra E, et al. Among authors: peserico a. Immunotherapy. 2013 Aug;5(8):791-4. doi: 10.2217/imt.13.82. Immunotherapy. 2013. PMID: 23902545 Review. No abstract available.

5

Contact Sensitization in Children: A Retrospective Study of 2,614 Children from a Single Center.

Belloni Fortina A, Fontana E, Peserico A. Belloni Fortina A, et al. Among authors: peserico a. Pediatr Dermatol. 2016 Jul;33(4):399-404. doi: 10.1111/pde.12873. Epub 2016 May 31. Pediatr Dermatol. 2016. PMID: 27241536

6

Absent or low expression of T-cell receptor zeta-chain in T cells infiltrating human pathological skin conditions.

Alaibac M, Pigozzi B, Saponeri A, Belloni-Fortina A, Peserico A. Alaibac M, et al. Among authors: peserico a. Arch Dermatol Res. 2002 Nov;294(8):380-2. doi: 10.1007/s00403-002-0343-x. Epub 2002 Sep 14. Arch Dermatol Res. 2002. PMID: 12420108

7

CD7 expression in reactive and malignant human skin T-lymphocytes.

Alaibac M, Pigozzi B, Belloni-Fortina A, Michelotto A, Saponeri A, Peserico A. Alaibac M, et al. Among authors: peserico a. Anticancer Res. 2003 May-Jun;23(3B):2707-10. Anticancer Res. 2003. PMID: 12894562

8

Immunoglobulin heavy chain variable region family expression in primary cutaneous follicle centre cell lymphomas.

Alaibac M, Belloni-Fortina A, Mori M, Pigozzi B, Peserico A, Pimpinelli N. Alaibac M, et al. Among authors: peserico a. Br J Dermatol. 2001 Apr;144(4):862-5. doi: 10.1046/j.1365-2133.2001.04146.x. Br J Dermatol. 2001. PMID: 11298550

9

Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.

Fortina AB, Piaserico S, Caforio AL, Abeni D, Alaibac M, Angelini A, Iliceto S, Peserico A. Fortina AB, et al. Among authors: peserico a. Arch Dermatol. 2004 Sep;140(9):1079-85. doi: 10.1001/archderm.140.9.1079. Arch Dermatol. 2004. PMID: 15381547

10

Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy.

Piaserico S, Alaibac M, Fortina AB, Peserico A. Piaserico S, et al. Among authors: peserico a. J Am Acad Dermatol. 2006 Feb;54(2):338-40. doi: 10.1016/j.jaad.2005.06.023. J Am Acad Dermatol. 2006. PMID: 16443071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters